Table 1 Characteristics of in-depth interview study participants, N = 85
ProBE/ProtecT participants N = 38 | ProtecT participants N = 47 | All participants | ||
|---|---|---|---|---|
No infection (N = 33, A1-A33) | Infection (i) (N = 5, A34i-A38i) | (N = 47, B39—B85) | (N = 85) | |
Age at time of first biopsy: mean (SD) | 64.3 (4.9) | 60.8 (4.9) | 63.5 (4.5) | 63.6 (4.7) |
Employment status N (%) | ||||
Full time | 14 | 5 | 24 | 43 |
Not working | 18 | 0 | 20 | 38 |
Part time | 0 | 0 | 0 | 0 |
Not specified/missing | 1 | 0 | 3 | 4 |
Ethnicity, N (%) | ||||
White | 33 | 5 | 46 | 84 |
Other | 0 | 0 | 1 | 1 |
Centre, N (%) | ||||
1 | 3 | 0 | 0 | 3 |
2 | 1 | 0 | 9 | 10 |
3 | 16 | 3 | 30 | 49 |
4 | 2 | 0 | 8 | 10 |
5 | 4 | 0 | 0 | 4 |
6 | 3 | 1 | 0 | 4 |
7 | 2 | 1 | 0 | 3 |
8 | 2 | 0 | 0 | 2 |
Initial PSA result ng/ml, median (Interquartile range) | 6.0 (3.7 to 13.0) | 4 (3.4 to 4.7) | 4.3 (3.5 to 6.7) | 4.5 (3.5 to 7.2) |
Biopsy result | (Final biopsy) | |||
Benign | 12 | 1 | 0 | 13 |
Localized cancer | 12 | 4 | 47 | 63 |
Advanced cancer | 9 | 0 | 0 | 9 |
Number of biopsies at time of interview | ||||
1 | 33 | 5 | 35 | 73 |
2 | 0 | 0 | 10 | 10 |
3 | 0 | 0 | 2 | 2 |
Interview type | ||||
Telephone | 18 | 5 | 0 | 23 |
Face to face | 15 | 0 | 47 | 62 |
Timing of interview N weeks post-biopsy Median (range) mean | 10 (3–138) 33 | 18 (10–72) 35 | 41 (9–75)* 41 | 40 (3–138) 39 |
Treatment of infection | ||||
Hospital admission | n/a | 3 | n/a | 3 |
Family physician | n/a | 2 | 1** | 3 |
Cancer treatment | ||||
Radical prostatectomy | − | - | 17 | 17 |
Radical radiotherapy | - | - | 15 | 15 |
Active monitoring | - | - | 15 | 15 |
Other | - | - | 0 | 0 |